Mortgage Blog

The U.S. Food and Drug Administration has rejected a drug made by a Lexington biotech just a few months after it rejected another drug by the same company.

The agency's authorization opens the door to 194 markets.

A Germantown software firm that attracted a $156 million private equity investment this summer named former Zywave president Jim Emling executive chairman during a new phase of growth.

Does this scientist's research into a possible early treatment offer false hope for Alzheimer's Disease patients and their families? Will a clinical trial put doubts to rest?

By day, Sasha Surkin is a student at UNC-Chapel Hill. But in her free time she’s the CEO of her own eyewear company.

The company hopes to win FDA approval of its blood cancer drug imetelstat by mid-June.

A drug made by Dutch biotech argenx SE, which has U.S. offices in Cambridge, met a surprise failure in a late-stage study, sending share prices down on Tuesday morning.

Lillian Bernier said her employer-sponsored health plan excluded coverage for gender-affirming care—and she's arguing that exclusion violates state and federal discrimination laws.

Does this scientist's research into a possible early treatment offer false hope for Alzheimer's Disease patients and their families? Will a clinical trial put doubts to rest?

The organization is piloting the app with a school in Pueblo.